Investing Profile

Michael Nally

InvestorVCCEO
CEO/Partner at Flagship Pioneering
Photo of Michael Nally, Partner at Flagship Pioneering

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Harvard Business School Network
752 CONNECTIONS
The London School of Economics and Political Science (LSE) Network
321 CONNECTIONS
Flagship Pioneering Network
86 CONNECTIONS
Middlebury College Network
65 CONNECTIONS
Merck Network
55 CONNECTIONS
cb
$500K - $15.0M
$7.0M
2
CompanyStageDateRound SizeTotal Raised
Generate Biomedicines
Series CSep 2023$270M
Series BNov 2021$370M
$640M
Co-investors: Noubar Afeyan (Flagship Pioneering), David Beazley (Castor Ventures (an Alumni Ventures Fund)), Jamie Montgomery (March Capital)
Senior Financial Analyst, Corporate Financial Services MerckPresent
Manager, Worldwide Human Health Financial Services MerckPresent
Director, Investor Relations MerckPresent
Director Business Development MerckPresent
Executive Director, Global Human Health Operations and Execution MerckPresent
Executive Director, Strategic Initiatives and Operations MerckPresent
Managing Director, Sweden MSDPresent
Managing Director, UK and Ireland MSDPresent
President, Merck Vaccines MerckPresent
Chief Marketing Officer, Human Health MerckPresent
Board Member PPGPresent
Board Member PPG PeoplePresent
Member Board Of Directors Harbinger HealthPresent
CEO/Partner Flagship PioneeringPresent
CEO at Generate Biomedicines Generate:BiomedicinesPresent
Middlebury College Bachelor's degree Economics
The London School of Economics and Political Science (LSE) General Course Accounting and Finance
Harvard Business School Master of Business Administration (MBA) General Management
Sign in with Google →
Sign in with Google →